Inmune Bio, Inc.
INMBAs of the close on Sep 25, 2026
Price
$2.03
Market cap
$56.3M
P/E (diluted TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
EPS (TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Inmune Bio, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 8 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Dec 2, 2025. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 2026-03-31 | 17,000 | Not shown | SEC filing |
| SBI Securities Co., Ltd. | 2026-03-31 | 833 | Not shown | SEC filing |
| Russell Investments Group, Ltd. | 2026-03-31 | 13,993 | Not shown | SEC filing |
| MAI Capital Management | 2026-03-31 | 4,271 | Not shown | SEC filing |
| DAVENPORT & Co LLC | 2026-03-31 | 10,000 | Not shown | SEC filing |
| AQR CAPITAL MANAGEMENT LLC | 2026-03-31 | 270,317 | Not shown | SEC filing |
| Focus Partners Advisor Solutions, LLC | 2026-03-31 | 43,025 | Not shown | SEC filing |
| CWM, LLC | 2026-03-31 | 13,120 | Not shown | SEC filing |
| Dauntless Investment Group, LLC | 2026-03-31 | 183,476 | Not shown | SEC filing |
| Nuveen, LLC | 2026-03-31 | 16,518 | Not shown | SEC filing |
| GAMMA Investing LLC | 2026-03-31 | 1,604 | Not shown | SEC filing |
| IEQ CAPITAL, LLC | 2026-03-31 | 24,563 | Not shown | SEC filing |
| True Wealth Design, LLC | 2026-03-31 | 11 | Not shown | SEC filing |
| Arax Advisory Partners | 2026-03-31 | 66 | Not shown | SEC filing |
| Legal & General Group Plc | 2026-03-31 | 1,520 | Not shown | SEC filing |
| Tower Research Capital LLC (TRC) | 2026-03-31 | 11,772 | Not shown | SEC filing |
| RAYMOND JAMES FINANCIAL INC | 2026-03-31 | 203,245 | Not shown | SEC filing |
| LMR Partners LLP | 2026-03-31 | 16,600 | Not shown | SEC filing |
| TrinityBridge Ltd | 2026-03-31 | 2,000 | Not shown | SEC filing |
| NEW YORK STATE COMMON RETIREMENT FUND | 2026-03-31 | 500 | Not shown | SEC filing |
- Each value is checked against Inmune Bio, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- Keating Financial Advisory Services, Inc.: 200 shares reported 2025-12-31; 200 shares reported 2026-03-31.
- XTX Topco Ltd: 68,865 shares reported 2025-12-31; 30,306 shares reported 2026-03-31.
- Federation des caisses Desjardins du Quebec: 400 shares reported 2025-12-31; 400 shares reported 2026-03-31.
- Quadrature Capital Ltd: 16,961 shares reported 2025-12-31; 32,362 shares reported 2026-03-31.
- DEUTSCHE BANK AG\: 6,923 shares reported 2025-12-31; 296 shares reported 2026-03-31.
- MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.: 9,967 shares reported 2025-12-31; 10,205 shares reported 2026-03-31.
- UBS Group AG: 60,803 shares reported 2025-12-31; 253,340 shares reported 2026-03-31.
- CITIGROUP INC: 1,803 shares reported 2025-12-31; 1,472 shares reported 2026-03-31.
- GOLDMAN SACHS GROUP INC: 56,477 shares reported 2025-12-31; 231,586 shares reported 2026-03-31.
- IFP Advisors, Inc: 195 shares reported 2025-12-31; 210 shares reported 2026-03-31.
- Ameritas Investment Partners, Inc.: 1,196 shares reported 2025-12-31; 1,196 shares reported 2026-03-31.
- JPMORGAN CHASE & CO: 41,365 shares reported 2025-12-31; 33,245 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
40 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Inmune Bio, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2021-07-09 · Schroeder Timothy j: Larger than 21 of the 22 other insider sales of Common Stock on file. SEC filing
- 2021-07-08 · Tesi Raymond Joseph: Larger than 20 of the 22 other insider sales of Common Stock on file. SEC filing
- 2020-01-27 · Powers Linda F: Larger than all 22 other insider sales of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2024-09-12–2024-09-12: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2024-09-12–2024-09-12: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2022-05-26–2022-05-27: 3 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2019-08-20–2019-08-21: 11 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing )
- 2019-06-03–2019-06-03: 4 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2024-09-30 | Moss David J · Chief Financial Officer | Common Stock | P — Open market or private purchase | +10,000 | 5.29 | SEC filing |
| 2024-09-12 | Moss David J · Chief Financial Officer | Common Stock Warrants (right to buy) | P — Open market or private purchase | +7,690 | 0.13 | SEC filing |
| 2024-09-12 | Tesi Raymond Joseph · President and CEO | Common Stock | P — Open market or private purchase | +15,380 | 6.38 | SEC filing |
| 2024-09-12 | Moss David J · Chief Financial Officer | Common Stock | P — Open market or private purchase | +7,690 | 6.38 | SEC filing |
| 2024-09-12 | Tesi Raymond Joseph · President and CEO | Common Stock Warrants (right to buy) | P — Open market or private purchase | +15,380 | 0.13 | SEC filing |
| 2024-06-25 | Juda Scott · Director | Common Stock | P — Open market or private purchase | +5,000 | 7.27 | SEC filing |
| 2024-04-19 (amended) | Tesi Raymond Joseph · President and CEO | Common Stock | P — Open market or private purchase | +18,028 | 8.32 | SEC filing |
| 2024-04-19 (amended) | Juda Scott · Director | Common Stock Warrants (right to buy) | P — Open market or private purchase | +29,603 | 0.13 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2025-12-01 | Lowdell Mark William · Chief Scientific Officer | Option (right to buy) | A — Grant, award, or other acquisition | +600,000 | SEC filing |
| 2025-12-01 | Ellspermann Cory Randall · CFO | Option (right to buy) | A — Grant, award, or other acquisition | +300,000 | SEC filing |
| 2025-12-01 | Moss David J · Chief Executive Officer | Option (right to buy) | A — Grant, award, or other acquisition | +750,000 | SEC filing |
| 2025-12-01 | Schroeder Timothy j · Director | Option (right to buy) | A — Grant, award, or other acquisition | +150,000 | SEC filing |
| 2025-12-01 | Juda Scott · Director | Option (right to buy) | A — Grant, award, or other acquisition | +150,000 | SEC filing |
| 2025-12-01 | ALLEN MARCIA · Director | Option (right to buy) | A — Grant, award, or other acquisition | +150,000 | SEC filing |
| 2025-12-01 | Ganjei James Kelly · Director | Option (right to buy) | A — Grant, award, or other acquisition | +150,000 | SEC filing |
| 2025-11-18 | Ganjei James Kelly · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +108,000 | SEC filing |
Showing 8 of 16 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2025-11-18 | Juda Scott · Director | Stock Option (right to buy) | D — Disposition to the issuer | −108,000 | SEC filing |
| 2025-11-18 | Moss David J · Chief Executive Officer | Stock Option (right to buy) | D — Disposition to the issuer | −223,000 | SEC filing |
| 2025-11-18 | Ganjei James Kelly · Director | Stock Option (right to buy) | D — Disposition to the issuer | −35,000 | SEC filing |
| 2025-11-18 | Ganjei James Kelly · Director | Stock Option (right to buy) | D — Disposition to the issuer | −19,025 | SEC filing |
| 2025-11-18 | ALLEN MARCIA · Director | Stock Option (right to buy) | D — Disposition to the issuer | −35,000 | SEC filing |
| 2025-11-18 | Ellspermann Cory Randall · Interim CFO | Stock Option (right to buy) | D — Disposition to the issuer | −75,000 | SEC filing |
| 2025-11-18 | Moss David J · Chief Executive Officer | Stock Option (right to buy) | D — Disposition to the issuer | −160,000 | SEC filing |
| 2025-11-18 | ALLEN MARCIA · Director | Stock Option (right to buy) | D — Disposition to the issuer | −32,500 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.